Related Experiment Video
Updated: Jul 10, 2026
08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Development of dimeric modulators for anti-apoptotic Bcl-2 proteins
Liangyou Wang1, Fansen Kong, Candis L Kokoski
1Department of Medicinal Chemistry, University of Minnesota Minneapolis, MN 55455, USA.
Bioorganic & Medicinal Chemistry Letters
|November 21, 2007
Summary
Researchers developed dimeric modulators targeting anti-apoptotic Bcl-2 proteins. These dimeric compounds show enhanced binding and bioactivity compared to monomeric drugs, offering a promising strategy for Bcl-2 antagonist development.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Bcl-2 family proteins regulate apoptosis, with anti-apoptotic and pro-apoptotic members.
- These proteins interact via heterodimerization, while homodimerization mediates their functions.
- Current small-molecule antagonists are typically monomeric modulators of anti-apoptotic Bcl-2 proteins.
Purpose of the Study:
- To develop novel dimeric modulators based on the BH3I-1 scaffold.
- To explore the structure-activity relationships of these dimeric modulators.
- To compare the efficacy of dimeric versus monomeric Bcl-2 antagonists.
Main Methods:
- Synthesis of a series of BH3I-1 based dimeric modulators.
- Structure-activity relationship (SAR) studies.
- Assessment of binding activity against anti-apoptotic Bcl-2 proteins.
- Evaluation of cytochrome c release from mitochondria.
Main Results:
- Dimeric modulators exhibited enhanced binding affinity compared to monomeric antagonists.
- An acidic functional group was identified as critical for binding interactions.
- A representative dimeric modulator demonstrated superior activity in inducing cytochrome c release.
- Dimerization strategy significantly improved the bioactivity of Bcl-2 antagonists.
Conclusions:
- Dimerization of monomeric Bcl-2 modulators is an effective strategy to enhance bioactivity.
- BH3I-1 based dimeric compounds represent a promising class of Bcl-2 antagonists.
- Understanding the role of specific functional groups, like acidic moieties, is crucial for drug design.
Related Concept Videos
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.